ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

Abroad (travel likely)RecruitingPHASE2

Conditions

AChR-Ab Seropositive Generalized Myasthenia Gravis · Myasthenia Gravis · MG · gMG · Generalized Myasthenia Gravis · Generalized Myasthenia Gravis (gMG)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Profound Research LLC - Carlsbad, Carlsbad, California, United States
Contact: Study coordinator (Gregory Sahagian, MD) · greg@profoundresearch.com · 760-732-0557
Visionary Investigators Network, Miami, Florida, United States
Contact: Study coordinator (Andrew Lerman, MD) · alerman@fcneurology.net · 786-655-8010
University of South Florida, Tampa, Florida, United States
Contact: Study coordinator (Tuan Vu, MD) · tvu6@usf.edu · 813-974-9413
Henry Ford Health Systems, Detroit, Michigan, United States
Dent Neurologic Institute - Amherst, Amherst, New York, United States
Contact: Study coordinator (Luisa Rojas Estupinan, MD) · aemborsky@dentinstitute.com · 716-250-2000
Duke Early Phase Clinical Research Unit - PPDS, Durham, North Carolina, United States
Ohio State Martha Morehouse Outpatient Care, Columbus, Ohio, United States
Contact: Study coordinator (Miriam Freimer, MD) · Miriam.Freimer@osumc.edu · 614-293-4969
Erlanger Health System, Chattanooga, Tennessee, United States
Contact: Study coordinator (Joshua Alpers, MD) · joshua.alpers@erlanger.org · 423-778-3900
National Neuromuscular Research Institute, Austin, Texas, United States
Contact: Study coordinator (Yessar Hussain, MD) · marisol@austinneuromuscle.com · 512-920-0140
University of Texas- San Antonio - Health Science Center - PPDS, San Antonio, Texas, United States
Contact: Study coordinator (Ratna Bhavaraju-Sanka, MD) · BhavarajuSan@uthscsa.edu · 210-567-8229
UZ Leuven - PPDS, Leuven, Belgium
Contact: Study coordinator (Kristl Claeys, MD) · kristl.claeys@uzleuven.be · +3216344278
ASST Papa Giovanni XXIII - Ospedale Papa Giovanni XXIII, Bergamo, Lombardy, Italy
Contact: Study coordinator (Giorgia Camera, MD) · clinicaltrials@argenx.com · 857-350-4834
MICS Centrum Medyczne Bydgoszcz, Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
Contact: Study coordinator (Lukasz Rzepiński, MD) · lukasz.rzepinski@mics.medicover.com · +48523401414
Centrum Medyczne Neurologia Slaska, Katowice, Silesian Voivodeship, Poland
Contact: Study coordinator (Marek Smilowski, MD) · marek.smilowski@neurologiaslaska.pl · +48500282494
Hospital Regional Universitario de Malaga - Hospital General, Málaga, Malaga, Spain
Contact: Study coordinator (Guillermina Garcia Martin, MD) · guille.garcia.eecc@gmail.com · +34951291135

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

Myasthenia Gravis · MG · gMG

Abroad (travel likely)Recruiting

Carlsbad, United States · Miami, United States